1. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts 
Sam Norton, MSc, PhD, Bo Fu, MSc, PhD, David L. Scott, BSc, MD, FRCP, Chris Deighton, MD, Deborah P.M. Symmons, MD, FFPH, FRCP, Allan J. Wailoo, MSc, PhD, Jonathan Tosh, MSc, PhD, Mark Lunt, MSc, PhD, Rebecca Davies, MSc, Adam Young, MD, FRCP, Suzanne M.M Verstappen, MSc, PhD 
Seminars in Arthritis and Rheumatism 
Volume 44, Issue 2, Pages (October 2014)
DOI: /j.semarthrit
Copyright © 2014 The Authors Terms and Conditions

2. Fig. 1 Selection process publications.
Seminars in Arthritis and Rheumatism  , DOI: ( /j.semarthrit )
Copyright © 2014 The Authors Terms and Conditions

3. Fig. 2
Censored normal 4-class LCGM observed (- - -) and expected trajectories (–) of functional disability in NOAR and ERAS.
Seminars in Arthritis and Rheumatism  , DOI: ( /j.semarthrit )
Copyright © 2014 The Authors Terms and Conditions

4. Fig. 3
Percentage of patients receiving methotrexate (A) or biologics (B) during follow-up in each of the four class membership groups. —ERAS cohort and —NOAR cohort.
Seminars in Arthritis and Rheumatism  , DOI: ( /j.semarthrit )
Copyright © 2014 The Authors Terms and Conditions